Arista Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Arista Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176K	Hold	10,961	–	–	0.02%	265
2026 Q1	$203K	Hold	10,961	–	–	0.02%	249
2025 Q4	$171K	Hold	10,961	–	–	0.02%	247
2025 Q3	$160K	Hold	10,961	–	–	0.02%	265
2025 Q2	$169K	Buy	+10,961	New	+$162K	0.02%	236

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Arista Wealth Management's TAK Position: Q2 2026 in Review

Arista Wealth Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 10,961 shares worth $176K. The position accounts for 0.02% of the portfolio, ranked #265.

Arista Wealth Management first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $203K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Arista Wealth Management held 10,961 shares of Takeda Pharmaceutical worth $176K as of Q2 2026.
Arista Wealth Management left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.02% of Arista Wealth Management's portfolio in Q2 2026, its #265 holding.
Arista Wealth Management first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
Arista Wealth Management's Takeda Pharmaceutical position peaked at $203K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Arista Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.